Isbn: 9786209096495 - neuro protective effect of n6- isopentanyl adenosine: in alzhimers disease (9 resultados)

Condición: New.

PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

Taschenbuch. Condición: Neu. Neuro Protective Effect of N6- Isopentanyl Adenosine | In Alzhimers Disease | Anand VijayaKumar Parul Ramkrishnan (u. a.) | Taschenbuch | Englisch | 2026 | LAP LAMBERT Academic Publishing | EAN 9786209096495 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu.…

Paperback. Condición: new. Paperback. Alzheimer's disease (AD), the most prevalent form of dementia, is a progressive neurodegenerative disorder that affects millions, particularly in the aging population. Characterized by senile plaques, amyloid-beta (Ab) deposits, neurofibrillary tangles, and selective neuronal loss, AD leads to a gradual decline in cognitive function, memory, and daily functioning. While current treatments primarily target symptomatic relief by modulating neurotransmitter levels, they do little to halt the disease's progression.N6-Isopentyladenosine (iPA), a naturally occurring purine derivative, holds promise as a novel therapeutic approach in neurodegenerative diseases like Alzheimer's. With its remarkable anti-inflammatory, antioxidant, and anti-apoptotic properties, iPA has been shown to modulate key signaling pathways that promote neuronal survival and plasticity. Preclinical studies have demonstrated its potential to reduce inflammation, attenuate neuronal damage, and improve cognitive function in animal models, offering new hope for AD patients. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 76 pp. Englisch.

Paperback. Condición: new. Paperback. Alzheimer's disease (AD), the most prevalent form of dementia, is a progressive neurodegenerative disorder that affects millions, particularly in the aging population. Characterized by senile plaques, amyloid-beta (Ab) deposits, neurofibrillary tangles, and selective neuronal loss, AD leads to a gradual decline in cognitive function, memory, and daily functioning. While current treatments primarily target symptomatic relief by modulating neurotransmitter levels, they do little to halt the disease's progression.N6-Isopentyladenosine (iPA), a naturally occurring purine derivative, holds promise as a novel therapeutic approach in neurodegenerative diseases like Alzheimer's. With its remarkable anti-inflammatory, antioxidant, and anti-apoptotic properties, iPA has been shown to modulate key signaling pathways that promote neuronal survival and plasticity. Preclinical studies have demonstrated its potential to reduce inflammation, attenuate neuronal damage, and improve cognitive function in animal models, offering new hope for AD patients. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 76 pp. Englisch.

Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Alzheimer's disease (AD), the most prevalent form of dementia, is a progressive neurodegenerative disorder that affects millions, particularly in the aging population. Characterized by senile plaques, amyloid-beta (Abeta) deposits, neurofibrillary tangles, and selective neuronal loss, AD leads to a gradual decline in cognitive function, memory, and daily functioning. While current treatments primarily target symptomatic relief by modulating neurotransmitter levels, they do little to halt the disease's progression.N6-Isopentyladenosine (iPA), a naturally occurring purine derivative, holds promise as a novel therapeutic approach in neurodegenerative diseases like Alzheimer's. With its remarkable anti-inflammatory, antioxidant, and anti-apoptotic properties, iPA has been shown to modulate key signaling pathways that promote neuronal survival and plasticity. Preclinical studies have demonstrated its potential to reduce inflammation, attenuate neuronal damage, and improve cognitive function in animal models, offering new hope for AD patients. …